
    
      The present study is designed as a prospective, open label, observational study.

      The study will collect information about the medical care patients receive during their
      planned procedure. No additional testing or procedures will be done.

      Patients elected for endovascular revascularization with SuperSub strategy will be asked
      their written consent to the use of their personal data.

      Revascularization will be performed as per standard procedure of the sites. After discharge
      all patients will attend clinic visits at 30 days (±14 days), 6 months (±30 days), 12 months
      (±30 days) and 24 months (±30 days). Angiographic follow-up will be performed only in
      symptomatic patients, as clinically indicated and with the aim for a new treatment.
    
  